Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has gained significant attention for weight management beyond its original diabetes indication
These aren't identical trial designs, so direct comparison has limits
Rare side effects (affecting less than 1% of users) Full-blown allodynia, where non-painful stimuli produce genuine pain across large body areas, appears to be rare based on current evidence
The origin of the problem lies in impaired redox homeostasis, which causes damage to cell membrane, compromising the viability and integrity of the central nervous system (CNS) (Van Horssen et al., 2011
Cuando empezamos a tomar algo para adelgazar, es comn que queramos ver los resultados de manera rpida, sin embargo, bajar de peso es un proceso complejo y depende del organismo de cada persona